N
Description
Norwegian clinical-stage biopharmaceutical company (Oslo Börs: NYKD), founded in 2006 by Agnete Fredriksen. Develops innovative vaccines and immunotherapies based on the Vaccibody molecule with strong immune response. Strategic partners: Roche and Regeneron. Over 150 employees at Oslo Science Park and Copenhagen.